Clifford Chance has advised the Hong Kong-listed SciClone Pharmaceuticals on an offer to take it private by healthcare-focused private equity firm GL Capital, with Slaughter and May acting for the buyer’s financial adviser, Capital Corporation Hong Kong Securities (CICC).

Country Garden's entire offshore debt will be deemed to be in default if China's largest private property developer fails to make a $15 million coupon payment on Tuesday, the end of a 30-day grace period.

China’s dynamic finance industry has been evolving rapidly in the past year or two in the face of increasing regulatory scrutiny as well as the growing impact of technology. Legal department heads say that while the current landscape poses certain challenges, it also brings with it a number of distinct opportunities that in-house teams are helping their companies take advantage of.